An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia
NCT07582874 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2026-05-13
Summary
The Expanded Access Program will provide access to avexitide for people with post-bariatric hypoglycemia (PBH) following Roux-en-Y gastric bypass (RYGB) who meet the eligibility criteria for this program. The safety of avexitide and patient treatment experience will be monitored during this program.
Conditions
- Post-bariatric Hypoglycemia
Interventions
- DRUG
-
90 mg subcutaneous injection once per day at least one hour prior to first meal of the day.
Sponsors & Collaborators
-
Amylyx Pharmaceuticals Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery
NCT00411489 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass
NCT05640947 ·Status: RECRUITING ·Phase: NA
-
Roux-en-Y Gastric Bypass: Clinical Trial
NCT04649619 ·Status: UNKNOWN ·Phase: NA
-
Extending and Banding the Roux-en-Y Gastric Bypass
NCT05357807 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
GAstric Bypass to Treat obEse Patients With steAdy hYpertension
NCT01784848 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass
NCT04172116 ·Status: UNKNOWN
-
Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection
NCT01341028 ·Status: COMPLETED ·Phase: NA
-
Impact of Implementation of an Enhanced Recovery After Surgery Program in Laparoscopic Roux-en-Y Gastric Bypass
NCT03212573 ·Status: UNKNOWN ·Phase: PHASE3
-
Banded Versus Non-banded Roux-en-y Gastric Bypass
NCT02545647 ·Status: COMPLETED ·Phase: NA
-
StomaphyX Versus Sham for Revisional Surgery in Post-Roux-en-Y Patients to Reduce Regained Weight
NCT00939055 ·Status: TERMINATED ·Phase: NA
-
Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes
NCT02207777 ·Status: COMPLETED ·Phase: NA
-
The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery
NCT02336438 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Comparison of Lap and Robotic-Assisted RYGB and SG
NCT04329780 ·Status: COMPLETED
-
The Effect of Roux-en-Y Gastric Bypass on Mitochondrial Function in Type 2 Diabetes
NCT01468116 ·Status: UNKNOWN
-
Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss
NCT03238794 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.
NCT03821636 ·Status: RECRUITING ·Phase: NA
-
MINI Bypass Versus Roux-en-Y Bypass: Differences in HOrmonal Secretions at 2 Years of Surgery
NCT03482895 ·Status: COMPLETED
-
Standard Versus "Single Loop" Bypass After Parietal Gastrectomy
NCT07115836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Changes in Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01993511 ·Status: UNKNOWN
-
Assessing the Safety and Performance of the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Gastric Bypass Surgery
NCT03968757 ·Status: COMPLETED
-
A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass
NCT04609449 ·Status: COMPLETED ·Phase: NA
-
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
NCT05446415 ·Status: UNKNOWN ·Phase: NA
-
Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients
NCT02625649 ·Status: COMPLETED
-
Sleeve Gastrectomy as a Standard Bariatric Procedure
NCT05336331 ·Status: ACTIVE_NOT_RECRUITING
-
Gastric Bypass With Different Lengths of the Bilipancreatic Limb
NCT05334173 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA